Page 3 - Biotechnology Vector News Today

Some 12.1 mln have received their first vaccine dose, Deputy Prime Minister Tatyana Golikova said MOSCOW, April 27. /TASS/. More than 12 mln Russians have received at least one dose of a coronavirus vaccine, and 7.7 mln have been fully vaccinated, Deputy Prime Minister Tatyana Golikova said at a meeting of the Council of Legislators of the Russian Federation on Tuesday. "As many as 12.1 mln of our fellow citizens have received their first vaccine dose and 7.7 mln have been fully vaccinated," sh...

8 Apr in 13:00 Just one day will be enough to update Russias EpiVacCorona vaccine to ensure protection against new mutations of the coronavirus, the Russian State Research Center of Virology and Biotechnology Vectors General Director Rinat Maksyutov said. "If the virus suddenly mutates, and a mutation occurs in the areas where we selected peptides, if we need to update the vaccine, then it will take no more than one day to upgrade vaccine composition," Maksyutov said. Vectors director clar...

Providing enough doses of the vaccine for Russians remains a priority, according to the researcher Read also MOSCOW, April 7. /TASS/. Russia’s center Vector has received many requests already for the anti-coronavirus vaccine EpiVacCorona from abroad and such messages keep pouring in, but providing enough doses of the vaccine for Russians remains a priority, the chief of Vector’s Yekaterinburg Research Institute of Viral Infections, Alexander Semyonov, said on the Vesti FM radio station on W...

EpiVacCorona was a second vaccine to have been certified in Russia MOSCOW, April 7. /TASS/. The vaccine EpiVacCorona will be able to protect the vaccinated at least for one year, the chief of the Yekaterinburg Research Institute of Viral Infections (an affiliate of the center Vector), Alexander Semyonov, said on Wednesday. Read also "One year, certainly. Theoretically, its effects should last two years. For the time being we are cautious about official forecasts, because too little time has pas...

7 Apr in 15:40 Russia’s vaccine EpiVacCorona is effective against the British and South African mutations of the novel coronavirus, the chief of the Yekaterinburg Research Institute of Viral Infections Vector, Alexander Semyonov said on the Vesti FM radio station. "This vaccine [EpiVacCorona] works against all strains that exist, that are known at the moment, including the British, South American and South African ones," he said. Semyonov said should new coronavirus strains emerge, it would ...

According to Anna Popova, EpiVacCorona produces "quite strong and effective immunity" but works "rather slowly"

Anna Popova said that the antibodies neutralize both the common strain and the British one

MOSCOW, March 5. /TASS/. Mass inoculation with the EpiVacCorona vaccine developed by Russia’s State Research Center of Virology and Biotechnology Vector will begin in the second half of March, the center’s Director General Rinat Maksyutov told Vesti news show on Rossiya 1 Friday. "Our fellow citizens will be able to get vaccinated [with EpiVacCorona] starting in the second half of March," he said. In October 2020, EpiVacCorona became the second coronavirus vaccine registered in Russia. Th...

To improve the performance of our website, show the most relevant news products and targeted advertising, we collect technical impersonal information about you, including through the tools of our partners. You can find a detailed description of how we use your data in our Privacy Policy. For a detailed description of the technologies, please see the Cookie and Automatic Logging Policy. By clicking on the "Accept & Close" button, you provide your explicit consent to the processing of your data t...